Lifeboat Foundation

Newts are the only four-legged vertebrates that can regenerate their body parts, even as adults. When a newt loses a limb, a mass of cells called a blastema is generated at the stump, from which a new, fully functional limb is eventually regenerated. Can this remarkable ability be explained by genes shared by vertebrates, including humans, or by unique genes that the newt may have evolved?

In a study published in Scientific Reports, researchers at several Japanese universities, including the University of Tsukuba, and the University of Dayton, report the discovery of a novel gene, Newtic1, from the blastema of an adult newt. This gene is expressed in a subset of red blood cells and may contribute to limb regeneration in adult newts. Red blood cells, or erythrocytes, function to deliver oxygen around an animal’s body. Unlike the other cells in the mammalian body, the erythrocytes lack nuclei, allowing them to carry more oxygen and squeeze into fine blood vessels. In the newt and most other non-mammalian species, however, these cells contain a nucleus. Other than oxygen delivery, the function of these nucleated cells is unknown. This study provides, for the first time, an insight into the roles of these nucleated cells.

In the study, the researchers constructed a database of all the protein-coding genes from the Japanese fire-bellied newt that had been reported in the Japan newt research community. This database contained DNA sequence information of genes from 19 different tissues, including different regenerating organs and limb blastemas. To identify genes related to limb regeneration, they used statistical analyses to look for genes whose expression was increased in association with the formation of the limb blastema. From 694,138 sequences, they found 105,464 expressed in the limb blastema. Further screening of these sequences resulted in the identification of a single gene which was named Newtic1. Its existence in newt tissues was confirmed using both DNA- and protein-based methods. Similar genes exist in axolotl and another newt species, but not in any other species.

A shortage of antibiotics is causing doctors to prescribe incorrect antibiotics for certain infections. That, in turn, is allowing antibiotic resistant organisms to develop defenses and some of those may no longer be treatable with antibiotics.

Kelsey-Seybold doctor Shane Magee says there are lots of drug shortages.

Continue reading “The Antibiotic Resistance Crisis is worsening” »

http://www.thepathmag.com/can-you-actually-hack-your-dna-to-slow-down-aging/

Many technologies / interventions progressing down the development pathways in the coming years — but there are a lot of free, common sense adjustments you can make today:

https://player.fm/series/healthy-relationship-talk-radio/cel…1-2018

http://www.blogtalkradio.com/entrepreneursempower/2018/06/03…ira-pastor

A recently published case study from an ongoing clinical trial has revealed an experimental immunotherapy treatment has cured a breast cancer patient. The 49-year-old patient with advanced breast cancer was given three months to live before enrolling into the trial. Within weeks her tumors had disappeared and 22 months later she is still in complete remission.

The treatment being trialed is a modified form of what is called adoptive immunotherapy. The technique generally works by harvesting a person’s immune cells. Once collected, the cells are armed with cancer-recognizing molecules so that when they are reintroduced into the patient’s body they can home in on the tumors and kill them off.

This form of immunotherapy has frustratingly been inconsistent in early clinical trials, working well with some patients on certain cancers but proving less effective on others. In particular, the treatment hasn’t been hugely successful in treating common epithelial cancers. These cancers tend to harbor lower levels of mutations that are fundamental to programming the immune cells to hit their targets.

Immune cells from the woman’s own body used to wipe out tumours.

Ian Sample and Jessica Glenza

Mon 4 Jun 2018 11.00 EDT Last modified on Mon 4 Jun 2018 19.55 EDT.

Continue reading “Doctors hail world first as woman’s advanced breast cancer is eradicated” »

OLDSMAR — Cryo-Cell International, the local company that was the first private cord bank to separate and store stem cells, has acquired a public cord blood bank company based in Orlando for $14 million.

Cryo-Cell announced the acquisition of CORD: USE on Monday. The sale propels Cyro-Cell into the public cord blood banking business. Cryo-Cell co-CEO David Portnoy said the purchase will raise revenues by about 20 percent.

Cryo-Cell was founded in 1989 and now holds the stem cells of more than 500,000 families from 87 countries, according to the company. CORD: USE has agreements with hospital across the country to receive donations from mothers of babies’ chord blood while also storing families stem cells.

Continue reading “Oldsmar’s Cryo-Cell buys Orlando cord blood bank for $14 million” »

“This, of course, will deepen scientific and technological cooperation at the experts’ level in many areas, including but not limited to, advanced material sources. We are talking here of biotechnology, nanotechnology, data analysis, artificial intelligence, space technology, innovation policy,” Hernandez said.

By Genalyn Kabiling and Argyll Cyrus Geducos

Seoul, South Korea — The country’s vibrant relations with South Korea are expected to be strengthened with the planned cooperation accords on transportation safety, technological development, port expansion, and revitalized trade during President Duterte’s official visit.

Continue reading “Stronger, deeper PH-SoKor ties sought” »